Cargando…
Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutations
In 2015, as part of the Reproducibility Project: Cancer Biology, we published a Registered Report (Chroscinski et al., 2014) that described how we intended to replicate selected experiments from the paper "Melanoma genome sequencing reveals frequent PREX2 mutations" (Berger et al., 2012)....
Autores principales: | Horrigan, Stephen K, Courville, Pascal, Sampey, Darryl, Zhou, Faren, Cai, Steve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245968/ https://www.ncbi.nlm.nih.gov/pubmed/28100394 http://dx.doi.org/10.7554/eLife.21634 |
Ejemplares similares
-
Registered report: Melanoma genome sequencing reveals frequent
PREX2 mutations
por: Chroscinski, Denise, et al.
Publicado: (2014) -
Melanoma genome sequencing reveals frequent PREX2 mutations
por: Berger, Michael F., et al.
Publicado: (2012) -
Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
por: Horrigan, Stephen K
Publicado: (2017) -
Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma
por: Yang, Ming-Hui, et al.
Publicado: (2019) -
Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1
por: Liu, Xing, et al.
Publicado: (2013)